1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Drivers
4.2.1.1. Technological Advancements in Molecular Diagnostics
4.2.1.2. Innovations in PoC Tests
4.2.1.3. Increase in Focus and Funding for R&D of Diagnostic Products
4.2.1.4. Rising Geriatric Population
4.2.1.5. Rising Prevalence of Communicable and Non-communicable Diseases
4.2.2. Restraints
4.2.2.1. Unfavorable Regulatory Framework
4.2.2.2. High Cost of Molecular Diagnostic Tests
4.2.3. Opportunities
4.2.3.1. Companion Diagnostics to Offer New Growth Potential
4.2.4. Challenges
4.2.4.1. Lack of Skilled Professionals
4.3. Technology Trends
4.4. Regulatory Analysis
4.5. Pricing Analysis
5. Europe Molecular Diagnostics Market Assessment, by Product & Service
5.1. Overview
5.2. Reagents & Kits
5.3. Instruments/Systems
5.4. Software & Services
6. Europe Molecular Diagnostics Market Assessment, by Test Type
6.1. Overview
6.2. Lab Tests
6.3. PoC Tests
7. Europe Molecular Diagnostics Market Assessment, by Technology
7.1. Overview
7.2. Polymerase Chain Reaction (PCR)
7.3. In Situ Hybridization (ISH)
7.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
7.5. Chips and Microarray
7.6. Mass Spectrometry
7.7. Sequencing
7.8. Transcription Mediated Amplification (TMA)
7.9. Other Technologies
8. Europe Molecular Diagnostics Market Assessment, by Application
8.1. Overview
8.2. Infectious Diseases
8.2.1. Hepatitis
8.2.2. HIV
8.2.3. Healthcare-associated Infections (HAIs)
8.2.4. Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG)
8.2.5. Human papillomavirus (HPV)
8.2.6. Tuberculosis
8.2.7. Influenza
8.2.8. COVID-19
8.2.9. Other Infectious Diseases
8.3. Oncology
8.3.1. Breast Cancer
8.3.2. Colorectal Cancer
8.3.3. Lung Cancer
8.3.4. Prostate Cancer
8.3.5. Lymphoma Cancer
8.3.6. Leukemia Cancer
8.3.7. Cervical Cancer
8.3.8. Other Cancer Types
8.4. Genetic Testing
8.5. Neurological Diseases
8.6. Cardiovascular Diseases
8.7. Other Applications
9. Europe Molecular Diagnostics Market Assessment, by End User
9.1. Overview
9.2. Hospitals & Clinics
9.3. Diagnostic Laboratories
9.4. Academic & Research Institutes
9.5. Other End Users
10. Europe Molecular Diagnostics Market Assessment, by Geography
10.1. Overview
10.2. Germany
10.3. France
10.4. U.K.
10.5. Switzerland
10.6. Ireland
10.7. Belgium
10.8. Italy
10.9. Spain
10.10. Rest of Europe (RoE)
11. Competition Analysis
11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
11.5. Market Share Analysis, by the Key Player/Key Market Ranking, 2022
12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Development)
12.1. F. Hoffmann-La Roche Ltd.
12.2. Hologic, Inc.
12.3. QIAGEN N.V.
12.4. Danaher Corporation
12.5. bioMérieux S.A.
12.6. Becton, Dickinson and Company (BD)
12.7. Siemens Healthineers AG
12.8. DiaSorin S.p.A.
12.9. Abbott Laboratories
12.10. Thermo Fisher Scientific Inc.
12.11. Agilent Technologies, Inc.
12.12. Illumina, Inc.
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Europe Molecular Diagnostics Market, by Product & Service, 2021–2030 (USD Million)
Table 2 Europe Molecular Diagnostics Kits & Reagents Market, by Country/Region, 2021–2030 (USD Million)
Table 3 Europe Molecular Diagnostics Instruments/Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 4 Europe Molecular Diagnostics Software & Services Market, by Country/Region, 2021–2030 (USD Million)
Table 5 Europe Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 6 Europe Molecular Diagnostics Market for Laboratory Tests, by Country/Region, 2021–2030 (USD Million)
Table 7 Europe Molecular Diagnostics Market for PoC Tests, by Country/Region, 2021–2030 (USD Million)
Table 8 Europe Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 9 Europe Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Country/Region, 2021–2030 (USD Million)
Table 10 Europe Molecular Diagnostics Market for In Situ Hybridization (ISH), by Country/Region, 2021–2030 (USD Million)
Table 11 Europe Molecular Diagnostics Market for Isothermal Nucleic Acid Amplification Technology (INAAT), by Country/Region, 2021–2030 (USD Million)
Table 12 Europe Molecular Diagnostics Market for Microarrays, by Country/Region, 2021–2030 (USD Million)
Table 13 Europe Molecular Diagnostics Market for Mass Spectrometry, by Country/Region, 2021–2030 (USD Million)
Table 14 Europe Molecular Diagnostics Market for Sequencing, by Country/Region, 2021–2030 (USD Million)
Table 15 Europe Molecular Diagnostics Market for Other Technologies, by Country/Region, 2021–2030 (USD Million)
Table 16 Europe Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 17 Europe Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 18 Europe Molecular Diagnostics Market for Infectious Diseases Market, by Country/Region, 2021–2030 (USD Million)
Table 19 Europe Molecular Diagnostics Market for COVID-19 Testing, by Country/Region, 2021–2030 (USD Million)
Table 20 Europe Molecular Diagnostics Market for Hepatitis Testing, by Country/Region, 2021–2030 (USD Million)
Table 21 Europe Molecular Diagnostics Market for HIV Testing, by Country/Region, 2021–2030 (USD Million)
Table 22 Europe Molecular Diagnostics Market for CT/NG Testing, by Country/Region, 2021–2030 (USD Million)
Table 23 Europe Molecular Diagnostics Market for Human papillomavirus (HPV) Testing, by Country/Region, 2021–2030 (USD Million)
Table 24 Europe Molecular Diagnostics Market for Tuberculosis Testing, by Country/Region, 2021–2030 (USD Million)
Table 25 Europe Molecular Diagnostics Market for Influenza Testing, by Country/Region, 2021–2030 (USD Million)
Table 26 Europe Molecular Diagnostics Market for Healthcare-associated Infections (HAIs) Testing, by Country/Region, 2021–2030 (USD Million)
Table 27 Europe Molecular Diagnostics Market for Other Infectious Diseases Testing, by Country/Region, 2021–2030 (USD Million)
Table 28 Europe Molecular Diagnostics Market, by Type, 2021–2030 (USD Million)
Table 29 Europe Molecular Diagnostics Market for Oncology, by Country/Region, 2021–2030 (USD Million)
Table 30 Europe Molecular Diagnostics Market for Breast Cancer Testing, by Country/Region, 2021–2030 (USD Million)
Table 31 Europe Molecular Diagnostics Market for Colorectal Cancer Testing, by Country/Region, 2021–2030 (USD Million)
Table 32 Europe Molecular Diagnostics Market for Lung Cancer Testing, by Country/Region, 2021–2030 (USD Million)
Table 33 Europe Molecular Diagnostics Market for Prostate Cancer Testing, by Country/Region, 2021–2030 (USD Million)
Table 34 Europe Molecular Diagnostics Market for Lymphoma Testing, by Country/Region, 2021–2030 (USD Million)
Table 35 Europe Molecular Diagnostics Market for Leukemia Testing, by Country/Region, 2021–2030 (USD Million)
Table 36 Europe Molecular Diagnostics Market for Cervical Cancer Testing, by Country/Region, 2021–2030 (USD Million)
Table 37 Europe Molecular Diagnostics Market for Other Cancer Types Testing, by Country/Region, 2021–2030 (USD Million)
Table 38 Europe Molecular Diagnostics Market for Genetic Testing, by Country/Region, 2021–2030 (USD Million)
Table 39 Europe Molecular Diagnostics Market for Neurological Diseases, by Country/Region, 2021–2030 (USD Million)
Table 40 Europe Molecular Diagnostics Market for Cardiovascular Diseases, by Country/Region, 2021–2030 (USD Million)
Table 41 Europe Molecular Diagnostics Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 42 Europe Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 43 Europe Molecular Diagnostics Market for Hospitals & Clinics, by Country/Region, 2021–2030 (USD Million)
Table 44 Europe Molecular Diagnostics Market for Diagnostic Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 45 Europe Molecular Diagnostics Market for Academic & Research Institutes, by Country/Region, 2021–2030 (USD Million)
Table 46 Europe Molecular Diagnostics Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 47 Europe Molecular Diagnostics Market, by Country/Region, 2021–2030 (USD Million)
Table 48 Germany: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 49 Germany: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 50 Germany: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 51 Germany: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 52 Germany: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 53 Germany: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 54 Germany: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 55 France: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 56 France: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 57 France: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 58 France: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 59 France: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 60 France: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 61 France: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 62 U.K.: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 63 U.K.: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 64 U.K.: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 65 U.K.: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 66 U.K.: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 67 U.K.: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 68 U.K.: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 69 Switzerland: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 70 Switzerland: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 71 Switzerland: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 72 Switzerland: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 73 Switzerland: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 74 Switzerland: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 75 Switzerland: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 76 Ireland: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 77 Ireland: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 78 Ireland: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 79 Ireland: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 80 Ireland: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 81 Ireland: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 82 Ireland: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 83 Belgium: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 84 Belgium: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 85 Belgium: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 86 Belgium: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 87 Belgium: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 88 Belgium: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 89 Belgium: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 90 Italy: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 91 Italy: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 92 Italy: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 93 Italy: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 94 Italy: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 95 Italy: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 96 Italy: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 97 Spain: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 98 Spain: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 99 Spain: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 100 Spain: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 101 Spain: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 102 Spain: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 103 Spain: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 104 Rest of Europe: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 105 Rest of Europe: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 106 Rest of Europe: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 107 Rest of Europe: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 108 Rest of Europe: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 109 Rest of Europe: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 110 Rest of Europe: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 111 Recent Developments by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Estimation
Figure 7 Europe Molecular Diagnostics Market, by Product & Service, 2024 VS. 2030 (USD Million)
Figure 8 Europe Molecular Diagnostics Market, by Test Type, 2024 VS. 2030 (USD Million)
Figure 9 Europe Molecular Diagnostics Market, by Technology, 2024 VS. 2030 (USD Million)
Figure 10 Europe Molecular Diagnostics Market, by Application, 2024 VS. 2030 (USD Million)
Figure 11 Europe Molecular Diagnostics Market, by End User, 2024 VS. 2030 (USD Million)
Figure 12 Molecular Diagnostics Market, by Geography
Figure 13 Europe Molecular Diagnostics Market, by Product & Service, 2024 VS. 2030 (USD Million)
Figure 14 Europe Molecular Diagnostics Market, by Test Type, 2024 VS. 2030 (USD Million)
Figure 15 Europe Molecular Diagnostics Market, by Technology, 2024 VS. 2030 (USD Million)
Figure 16 Europe Molecular Diagnostics Market, by Application, 2024 VS. 2030 (USD Million)
Figure 17 Europe Molecular Diagnostics Market, by End User, 2024 VS. 2030 (USD Million)
Figure 18 Europe Molecular Diagnostics Market, 2024 VS. 2030 (USD Million)
Figure 19 Europe: Molecular Diagnostics Market Snapshot
Figure 20 Key Growth Strategies Adopted by Leading Players, 2020—2024
Figure 21 Europe Molecular Diagnostics Market: Competitive Benchmarking, by Product & Service
Figure 22 Europe Molecular Diagnostics Market: Competitive Dashboard
Figure 23 Europe Molecular Diagnostics Market: Market Share Analysis (2022)
Figure 24 F. Hoffmann-La Roche Ltd: Financial Overview (2022)
Figure 25 Hologic, Inc.: Financial Overview (2022)
Figure 26 QIAGEN N.V.: Financial Overview (2022)
Figure 27 Danaher Corporation: Financial Overview (2022)
Figure 28 bioMérieux S.A.: Financial Overview (2022)
Figure 29 Becton, Dickinson and Company: Financial Overview (2022)
Figure 30 Siemens Healthineers AG: Financial Overview (2022)
Figure 31 DiaSorin S.p.A.: Financial Overview (2022)
Figure 32 Abbott Laboratories: Financial Overview (2022)
Figure 33 Thermo Fisher Scientific Inc.: Financial Overview (2022)
Figure 34 Agilent Technologies, Inc.: Financial Overview (2022)
Figure 35 Illumina, Inc.: Financial Overview (2022)